81.89
-1.77 (-2.12%)
| Previous Close | 83.66 |
| Volume | 2,835,432 |
| Avg. Volume (3M) | 3,676,442 |
| Market Cap | 37,025,566,720 |
| Price / Earnings (TTM) | 17.31 |
| Price / Earnings (Forward) | 15.13 |
| Price / Sales | 1.76 |
| Price / Book | 3.26 |
| 52 Weeks Range | |
| Earnings Date | 28 Oct 2026 |
| TTM Dividend Yield | 0.18% |
| Profit Margin | 9.95% |
| Operating Margin (TTM) | 13.75% |
| Diluted EPS (TTM) | 4.73 |
| Quarterly Revenue Growth (YOY) | 7.20% |
| Quarterly Earnings Growth (YOY) | 37.90% |
| Total Debt/Equity (MRQ) | 87.71% |
| Current Ratio (MRQ) | 1.30 |
| Operating Cash Flow (TTM) | 2.42 B |
| Levered Free Cash Flow (TTM) | 1.83 B |
| Return on Assets (TTM) | 4.99% |
| Return on Equity (TTM) | 20.01% |
News Mood
AIStockmoo Score
| Value 30% | 0.8 |
| The price implies earnings growth of 9.7% a year; the business can fund about 15.0% a year. Counted for less, as its earnings have been uneven. info | |
| Around its usual valuation. Counted for less, as its earnings have been uneven. info | |
| Earns well above its cost of capital. info | |
| Strong profitability. Thin short-term liquidity. Positive cash flow. info | |
| From our AI Insight report's view of expected return against risk. info | NA |
| Relative Valuation info | NA |
| Holdings' Value info | NA |
| Risk Premium info | NA |
| Market Valuation info | NA |
| Timing 30% | 2.6 |
| No clear trend over the past year. Trading near its 52-week high. info | |
| In an uptrend: the price is above its moving averages, and they are rising. It is close to them. Volume is heavier on up days. info | |
| From our AI technical analysis of the chart. info | NA |
| Sentiment 20% | 0.7 |
| No recent price targets, so based on how targets have been revised. info | |
| Recent news mostly positive. info | |
| Holdings' Sentiment info | NA |
| Smart Money 20% | 2.6 |
| Institutions net +3.35% of shares in their latest 13F filings: 585 holders increased, 562 decreased (quarter to 30 Sep 2026). info | |
| Short interest -3.7% from 31 Aug to 30 Oct 2026, 4.9 days to cover (FINRA). info | |
| Insider Activity info | NA |
| Market and sector conditions are poor. | |
| Market environment cautious. info | |
| Sector lagging the market. | |
| The pillars agree, so the score is strengthened. | |
| Not in score | |
| Earnings per share have gone up and down. Earnings have been uneven. info | |
| Recent bullish reversal pattern: Bullish engulfing, Inverted hammer. info | |
| Above its medium-term trend line. info | |
| Price is high against its 52-week average. Up over 5 years. info | |
| Trend up on all three terms. Short-term momentum rising. info | |
| Price is near support. Levels trending down. info | |
| Final Score | 1.82 |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | GE HealthCare Technologies Inc. | Mixed | Bullish |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B | Score |
|---|---|---|---|---|---|
| GEHC | 37 B | 0.18% | 17.31 | 3.26 | 1.8 |
| DXCM | 30 B | - | 32.47 | 12.14 | 0.7 |
| PODD | 9 B | - | 21.76 | 6.16 | 0.2 |
| AXGN | 3 B | - | - | 6.85 | 1.2 |
| TMDX | 3 B | - | 23.23 | 6.08 | -0.2 |
| ESTA | 2 B | - | - | 132.92 | -2.1 |
Select this tab to load the latest available analysis.
|
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company’s sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%). |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Mid Value |
| % Held by Insiders | 0.44% |
| % Held by Institutions | 95.66% |
No data within this time range.
No data within this time range.
Institutions
Institutional ownership: 102.68%
| Positions | Holders | Shares |
|---|---|---|
| Increased | 585 | 36,955,609 |
| Decreased | 562 | 22,814,596 |
| New | 140 | 4,004,332 |
| Sold out | 124 | 2,997,335 |
SEC 13F filings via Nasdaq, latest filings up to 30 Sep 2026. Filings arrive up to 45 days after each quarter.
Short Interest
| Settlement | Shares | Days to cover |
|---|---|---|
| 30 Oct 2026 | 18,256,312 | 4.9 |
| 15 Oct 2026 | 19,374,350 | 5.1 |
| 30 Sep 2026 | 18,520,401 | 4.7 |
| 15 Sep 2026 | 16,909,543 | 5.5 |
| 31 Aug 2026 | 18,955,374 | 7.5 |
| 14 Aug 2026 | 17,427,194 | 5.9 |
FINRA short interest via Nasdaq, reported twice a month.
| Date | Type | Details |
|---|---|---|
| 19 Nov 2026 | Yahoo Finance |
A $467 Billion Fund Just Bought These 3 Stocks
Key TakeawaysA fund that manages $467 billion made Amazon, GE HealthCare and a third stock its three biggest new or added positions in the third quarter, per its 13F filed Nov. 13… |
| 19 Nov 2026 | Yahoo Finance |
GE HealthCare Wins FDA Nod for AI Feeding Tube Detection Software
GEHC secures FDA clearance for AI-powered feeding tube detection software, expanding bedside X-ray capabilities for adult and pediatric patients. |
| 19 Nov 2026 | Yahoo Finance |
GE HealthCare’s Phase 2 Results Support Advancement of Investigational Manganese-Based MRI Contrast Agent Mangaciclanol Into Phase 3 of LUMINA Clinical Trial
CHALFONT ST. GILES, England, November 19, 2026--GE HealthCare (Nasdaq: GEHC) today announced Phase 2 results support advancement into Phase 3 for its international, multicenter LUMINA trial of mangaciclanol, with a dose selection of 0.1mmol/kg. Mangaciclanol is an investigational manganese-based… |
| 18 Nov 2026 | Yahoo Finance |
GE HealthCare Expands Global Research Network for Photon-Counting CT
GEHC expands its global research network for Photonova Spectra to advance photon-counting CT applications, clinical adoption and diagnostic capabilities. |
| 18 Nov 2026 | Yahoo Finance |
GE HealthCare (GEHC) Stock May Be Below Fair Value Following Raised Guidance
GE HealthCare Technologies has just logged a strong past month, with the stock gaining 17.6%, and that kind of move naturally raises the question of whether the current share price is still grounded in its earnings power. With the stock closing at US$81.84, investors are asking how much of the… |
| 18 Nov 2026 | Yahoo Finance |
GE HealthCare Technologies (GEHC) Qualified AR Spine Navigation For OEC 3D CT
GE HealthCare Technologies (NasdaqGS:GEHC) gained qualification for OnPoint Surgical's augmented reality spine navigation with its OEC 3D CT system. The OnPoint AR spine platform is now cleared to work with installed OEC 3D units, expanding use cases for existing hospital hardware. GE HealthCare… |
| 18 Nov 2026 | Yahoo Finance |
GE HealthCare Technologies (GEHC) On FDA AI Clearance And Whether The Upside Is Priced In
GE HealthCare Technologies (GEHC) just picked up FDA 510(k) clearance for Critical Care Suite 3.0, putting AI-powered feeding tube detection directly on mobile X-ray devices and extending this capability to pediatric patients at the bedside. Investors have been digesting a busy run of product news… |
| 18 Nov 2026 | Yahoo Finance |
GE HealthCare brings advanced visualization into InteleViewer to support radiology workflows
CHICAGO, November 18, 2026--GE HealthCare (Nasdaq: GEHC) announced the integration of the AW ONE ecosystem, a unified ecosystem for post processing and advanced visualization, with InteleViewer, IntelePACS’ diagnostic viewer designed to support seamless radiology workflows.1 Clinicians can now… |
| 18 Nov 2026 | Yahoo Finance |
Does FDA Clearance Change The Bull Case For GE HealthCare Technologies (GEHC)?
GE HealthCare Technologies recently received FDA 510(k) clearance for Critical Care Suite 3.0, an AI-enabled mobile X-ray software that supports bedside feeding tube detection and assessment for both adult and pediatric patients without relying on internet connectivity. During the same period, the… |
| 17 Nov 2026 | Yahoo Finance |
RSNA 2026: OnPoint Surgical's FDA-Cleared AR Spine Navigation Qualified for Use with GE HealthCare's OEC 3D
OnPoint Surgical, Inc., developer of the FDA 510(k)-cleared OnPoint Augmented Reality Spine System, today announced that the system has been successfully qualified for operation with GE HealthCare's OEC 3D mobile cone-beam CT (CBCT) C-arm. The qualification, completed with GE HealthCare engineers… |
| 17 Nov 2026 | Yahoo Finance |
GE HealthCare’s Critical Care Suite 3.0 brings first on-device AI for feeding tube detection to X-ray imaging in adult and pediatric care
CHICAGO, November 17, 2026--GE HealthCare today announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for Critical Care Suite 3.0, an AI-enabled software designed to automatically detect feeding tubes on X-ray images and support assessment of tube… |
| 17 Nov 2026 | Yahoo Finance |
Here's Why You Should Add GEHC Stock to Your Portfolio Right Now
GE HealthCare's record backlog, strong Pharmaceutical Diagnostics growth and AI-powered innovations position it for long-term growth despite inflation and tariff risks. |
| 16 Nov 2026 | Yahoo Finance |
GEHC or SYK: Which Is the Better Value Stock Right Now?
GEHC vs. SYK: Which Stock Is the Better Value Option? |
| 16 Nov 2026 | Yahoo Finance |
GE HealthCare expands global collaborations to help define the future of photon-counting CT with Photonova™ Spectra
CHICAGO, November 16, 2026--GE HealthCare (Nasdaq: GEHC) today announced an expansion of its global clinical and research collaborations to advance Photonova Spectra,i the company's next-generation photon-counting CT system. Following recent global regulatory clearances, leading academic hospitals… |
| 13 Nov 2026 | Yahoo Finance |
GE HealthCare Forms MAGNUS Neuro Alliance to Advance MRI Research
GEHC's MAGNUS Neuro Alliance aims to advance neuroscience research, expand MRI applications and develop imaging biomarkers for neurological conditions. |
| 12 Nov 2026 | Yahoo Finance |
GE HealthCare Stock Outlook: Is Wall Street Bullish or Bearish?
Despite GE HealthCare’s underperformance relative to the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects. |
| 11 Nov 2026 | Yahoo Finance |
GE HealthCare: 3 Key Takeaways for Long-Term Investors
Multiyear supply contracts and higher-margin product launches may help position the company to sustain margin expansion amid industry chip shortages. |
| 10 Nov 2026 | Yahoo Finance |
GEHC Expands Vscan Air AI Capabilities With Lung Guidance & AutoAS
GE HealthCare expands Vscan Air's AI capabilities with Lung Guidance and AutoAS, enhancing cardiopulmonary assessments and point-of-care diagnostic support. |
| 10 Nov 2026 | Yahoo Finance |
GE HealthCare announces intent to establish MAGNUS Neuro Alliance to unlock new possibilities in MRI for neuroscience
CHICAGO, November 10, 2026--GE HealthCare (Nasdaq: GEHC) today announced the intent to establish a collaborative research network focused on advancing neuroscience research leveraging an ultra high-gradient head-only 3.0T MR system1. The MAGNUS2 Neuro Alliance will bring together researchers and… |
| 09 Nov 2026 | Yahoo Finance |
GE HealthCare (GEHC) Raised Full-Year Guidance. Here’s What’s Behind Its Recovery.
We recently published Forget the High-Beta Hype: 10 ‘Sleep Well at Night’ Stocks to Buy Now, and GE HealthCare Technologies (NASDAQ:GEHC) came in 8th on the list. Yahoo Finance reported that the S&P 500 fell more than 4% on Thursday, November 5, its worst day since the April 2025 tariff crash… |
| 07 Nov 2026 | Yahoo Finance |
GE HealthCare Technologies (GEHC) Led A $160 Million Cardiac Imaging Investment
GE HealthCare Technologies (NasdaqGS:GEHC) led Laza Medical's Series B round, raising US$160 million to fund AI-based cardiac imaging. The financing aims to advance robotic imaging systems for cardiac procedures using artificial intelligence tools in clinical workflows. The partners plan broader… |
| 05 Nov 2026 | Yahoo Finance |
GE HealthCare Unveils Allia Celeo to Advance Interventional Imaging
GEHC's Allia Celeo launch expands its interventional imaging portfolio with AI-powered precision, flexible workflows and predictive service capabilities. |
| 04 Nov 2026 | Yahoo Finance |
Laza Medical Raises Up to $160 Million in Series B Financing Led by GE HealthCare to Advance Intelligent Imaging for Transforming the Cath Lab
Laza Medical, Inc., a Shifamed portfolio company pioneering AI-powered robotic imaging solutions for cardiac interventions, today announced it has raised up to $160 million in Series B structured financing. GE HealthCare led the round, with participation from returning investors Unorthodox… |
| 04 Nov 2026 | Yahoo Finance |
GEHC Q3 Earnings Call Highlights Raised Outlook and Margin Risks
GE HealthCare raises its 2026 earnings outlook on strong Q3 results, but tariff risks, fourth-quarter growth concerns and margin pressures remain in focus. |
| 04 Nov 2026 | Yahoo Finance |
Tampa General Hospital Expands Advanced Image-Guided Care in Clinical Hybrid Operating Room Setting With GE HealthCare Allia Moveo
Tampa General Hospital (TGH) today announced the installation of GE HealthCare's Allia™ Moveo next-generation, image-guided therapy (IGT) solution into a clinical hybrid operating room at its hospital, part of the Tampa Medical & Research District (TMRD). |
| Show more | ||
| TTM Dividend Yield | 0.18% |
| 3Y Average Dividend Yield | 0.15% |
| Payout Ratio | 2.96% |
| Expected Next Dividend Payment | Feb 2027 |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 23 Oct 2026 | 22 Sep 2026 | 13 Nov 2026 | 0.04 Cash |
| 24 Jul 2026 | 30 Jun 2026 | 14 Aug 2026 | 0.035 Cash |
| 02 Apr 2026 | 12 Feb 2026 | 15 May 2026 | 0.035 Cash |
| 09 Jan 2026 | 24 Nov 2025 | 13 Feb 2026 | 0.035 Cash |
| 24 Oct 2025 | 24 Sep 2025 | 14 Nov 2025 | 0.035 Cash |
| 25 Jul 2025 | 01 Jul 2025 | 15 Aug 2025 | 0.035 Cash |
| 25 Apr 2025 | 27 Mar 2025 | 15 May 2025 | 0.035 Cash |
| 14 Jan 2025 | 21 Nov 2024 | 14 Feb 2025 | 0.035 Cash |
| 18 Oct 2024 | 18 Sep 2024 | 15 Nov 2024 | 0.03 Cash |
| 19 Jul 2024 | 26 Jun 2024 | 15 Aug 2024 | 0.03 Cash |
| 18 Apr 2024 | 22 Mar 2024 | 15 May 2024 | 0.03 Cash |
| 12 Jan 2024 | 08 Dec 2023 | 15 Feb 2024 | 0.03 Cash |
| 19 Oct 2023 | 22 Sep 2023 | 15 Nov 2023 | 0.03 Cash |
| 20 Jul 2023 | 23 Jun 2023 | 15 Aug 2023 | 0.03 Cash |
| 22 May 2023 | 25 Apr 2023 | 15 Jun 2023 | 0.03 Cash |
| Show more | |||
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2026 | 0.145 | 4 | 0.18 |
| 2025 | 0.140 | 4 | 0.17 |
| 2024 | 0.120 | 4 | 0.15 |
| 2023 | 0.090 | 3 | 0.12 |
Recent Signals candle patterns and EMA crosses
Technical Setup Medium
AI Technical Analysis
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |